Filana Therapeutics, Inc. (FLNA)

Filana Therapeutics, Inc. in the Healthcare sector is trading at $1.22 with a market capitalization of $66M. Wall Street consensus targets $6.50 (2 analysts), implying a +432.8% move over the next 12 months. The stock is currently near its 52-week low of $1.15, remaining 46.3% below its 200-day moving average. On fundamentals, Piotroski 3/9 flags weak fundamentals, Altman Z in the distress zone. Risk note: RSI 24 is oversold, raising the odds of a near-term bounce; MACD remains below its signal line. The Whystock Score of 35/100 signals elevated caution as multiple indicators diverge.